Jopling Leprosy Book 6th Edition Pdf VERIFIED Free Download
Lynelle Bookmiller
Objectives: Different methods for the classification of leprosy have been proposed since the 1930s. The aim of this study was to compare the current methods at a referral center in Brazil.
Kabir Sardana MD, DNB, MNAMS was born in Dehradun and he was schooled around the country due to the frequent and predictable transfers of his father who was in the Indian Army.He graduated (MBBS, 1991) from Maulana Azad Medical College (MAMC), New Delhi with MD (Dermatology,Venereology and Leprosy) later (2000) from Lady Hardinge Medical College (LHMC), New Delhi. He has worked in various capacities in LHMC,MAMC,Chacha Nehru Bal Chikitsalaya and Dr RML Hospital and was a Professor of Dermatology, initially at MAMC and presently at the PGIMER & Dr RML Hospital, New Delhi. Leprosy is still an existential problem, with implications beyond the figures listed in guidelines. With 195 pubmed articles and 18 published books to his credit, he realized that what's needed for dermatologists is not another book to practice cosmetology, but to refresh the art of clinical dermatology, exemplified by leprosy. When not writing, he likes to read philosophy, tries to live the philosophy he reads and inspire others to do the same. As with all other things he would like to go back someday to where he arrived at, not philosophically which we all ultimately would,but literally to his birthplace, someday.
processing.... window.isQuestionAnswerPage = true; Drugs & Diseases > Infectious Diseases > Leprosy Q&A What is the Ridley-Jopling classification of leprosy? Updated: Apr 07, 2023
- Author: Darvin Scott Smith, MD, MSc, DTM&H, FIDSA; Chief Editor: Michael Stuart Bronze, MD more...
- References
- Share Print Feedback
- Facebook Twitter LinkedIn WhatsApp Email
A 24-months prospective study was conducted with clinically diagnosed leprosy cases in a tertiary care hospital in eastern India. Lesions were graded and the histopathological slides along with its bacteriological index (BI) on slit skin smears where possible was reviewed and analyzed. Agreement of histopathological finding with clinical finding was established.
At present there are two systems of classification in use throughout the world. The Ridley-Jopling classification dates back to 1966, and is based upon the clinical features, histopathology, and the bacteriological index (BI). Its usefulness is compounded by its correlation with host immune activity. It provides room for ascending and descending leprosy reactions which can alter the stage of borderline patients.
Tuberculoid leprosy is characterized by increased cellular immunity with localized infection, whereas lepromatous leprosy (LL) patients tend to have more disseminated infection and higher antibody levels, which are not effective, however, in checking bacillary proliferation.
The diagnosis of leprosy remains primarily clinical. In addition to skin lesions, the presence of anesthesia or hypoesthesia, thickening of peripheral nerves, and/or the presence of AFB on slit skin smears or biopsy, is noted. Mycobacterial culture has so far proved impossible in vitro. When a biopsy is required, it is taken from a sensory cutaneous nerve without muscular supply, such as the sural nerve or radial cutaneous nerve.
Leprosy is a neglected infectious disease caused by acid-fast bacillus Mycobacterium leprae. It primarily affects the skin and then progresses to a secondary stage, causing peripheral neuropathy with potential long-term disability along with stigma. Leprosy patients account for a significant proportion of the global disease burden. Previous efforts to improve diagnostic and therapeutic techniques have focused on leprosy in adults, whereas childhood leprosy has been relatively neglected. This review aims to update the diagnostic and therapeutic recommendations for adult and childhood leprosy. This review summarizes the clinical, bacteriological, and immunological approaches used in the diagnosis of leprosy. As strategies for the diagnosis and management of leprosy continue to develop better and more advanced knowledge, control and prevention of leprosy are crucial.
Patients with a strong cell-mediated immune reaction had few lesions with low or undetectable mycobacteria and were classified as having tuberculoid forms, whereas patients anergic to M. leprae had multiple lesions with higher loads of mycobacteria and were classified as having lepromatous forms [21]. Where an affected person falls within the classification model depends on their immune response [22]. Tuberculoid forms show little evidence of M. leprae-specific antibodies but a vigorous T helper (Th)1 cytokine response, whereas lepromatous forms show a Th2 cytokine response with markedly high antibody titers but T-cell hypo-response (anergy) [19, 25]. The balance of the Th1/Th2 response alone cannot fully explain the response to leprosy. Other T-cell subsets have been identified to play an important role in determining host immunity [25]. Tuberculoid leprosy is stable, rarely contagious, or self-limiting. The bacillus is not detectable by bacteriological analysis, but the Mitsuda reaction (lepromin test) is positive, and granulomas are typically found on biopsy. Borderline cases are classified as borderline lepromatous, borderline tuberculoid, or mid-borderline leprosy according to the pole (lepromatous or tuberculoid) they tend toward [21, 22]. Patients who have not yet developed a cell-mediated immune response to organisms are classified as having indeterminate leprosy (IL) [26]. If left untreated, they can progress to either tuberculoid or lepromatous disease.
All the above-mentioned classifications were also used to classify the clinical forms of childhood leprosy [20]. It is assumed that the largest number of childhood leprosy cases is in the indeterminate clinical form; however, there was an average proportion (23%) of this form of the disease in a study of the Brazilian childhood population [10]. A delayed diagnosis may be the reason for this paradox.
Leprosy reactions are caused by an immune response between the host and M. leprae. Leprosy reactions are an important consequence of permanent nerve damage during leprosy [30]. Leprosy reactions include acute/subacute inflammatory processes that mainly involve the skin and nerves and are the primary cause of morbidity and neurological disability. They may occur regularly at any stage of the disease, even without treatment [30]. However, this reaction can also be initiated or aggravated by effective chemotherapy due to the active destruction of bacilli during or after treatment, thereby producing an abundance of antigenic material in the immune system [31, 32]. Leprosy reactions can be subdivided into types 1 and 2.
Taken together, leprosy reactions are consequences of the dynamic immune response to M. leprae that may occur before, during, or after the completion of MDT for leprosy. It is the main cause of nerve damage and disability in children with leprosy. Children are a vulnerable social group and cannot be expected to seek help from health professionals. Therefore, it is important to ensure that families are involved in monitoring the signs and symptoms of leprosy in their children.
Clinical evaluation is the first step in the diagnosis of leprosy and is generally sufficient in most cases. However, one of the challenges in diagnosing leprosy is simply to consider this disease in the list of differential diagnoses, particularly in developed countries where leprosy has almost been eradicated or is extremely rare [26]. Obtaining travel or family history (e.g., adopted or immigrated from an endemic area) is important when considering a diagnosis of leprosy. In addition, practical information about the protective measures of the care team (e.g., high index of suspicion and wearing gloves) to prevent transmission should be included.
Skin lesions are usually the first clinical manifestation observed. If appropriate medical treatment is not received, leprosy may progress to cause permanent damage to the skin, nerves, limbs, and other organs [36]. WHO experts have listed the main diagnostic criteria as follows [22]: (1) a hypopigmented or erythematous skin lesion or reddish skin patch with definite loss of sensation; (2) a thickened or enlarged peripheral nerve with loss of sensation and/or weakness of muscle supplied by the nerve; and (3) a positive acid-fast skin smear or bacilli observed in a skin smear/biopsy. When all three signs were present, diagnostic accuracy was as high as 95% [26, 36].
The clinical diagnosis of leprosy is dependent on the recognition of disease signs and symptoms and is therefore only possible once the disease has manifested. Physical examination does not identify the early stages of the disease when clinical manifestations are rare [36, 53]. Previous studies showed that untrained health practitioners may not be effective in recognizing early signs of the disease [36, 55]. It is likely that clinical diagnosis is delayed or even missed, especially in regions where leprosy is controlled [56]. This finding might be related to a long delay between disease onset and diagnosis as well as a high rate of disability in grade 2 among new-child patients. In addition, it is difficult to conduct a thermal reaction test in younger children, which is necessary for the differential diagnosis of other childhood cutaneous lesions. Simple and objective tests to detect leprosy infection are necessary to assist clinicians in the early diagnosis of leprosy and to detect leprosy before its clinical signs manifest.
df19127ead